Mehdi Rajabi

4PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 25, 2024
RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780.

Kavitha Godugu, Mehdi Rajabi, Shaker A Mousa

|Nov 11, 2022
Correction: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780.

Kavitha Godugu, Mehdi Rajabi, Shaker A Mousa

|Apr 21, 2022
Effects of Anticancer Agent P-bi-TAT on Gene Expression Link the Integrin Thyroid Hormone Receptor to Expression of Stemness and Energy Metabolism Genes in Cancer Cells.

Gennadi V Glinsky, Kavitha Godugu, Thangirala Sudha

|Jul 02, 2021
Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma.

Kavitha Godugu, Mehdi Rajabi, Shaker A Mousa

Pageof 1

Frequent Collaborators

4 joint publications

Shaker A Mousa

1 joint publications

Gennadi V Glinsky

1 joint publications

Paul J Davis